Hans Thorleif Moller
Fondateur chez Ranger Biotechnologies A/S
Profil
Hans Thorleif Moller is the founder.
He founded Profylakse ApS in 1999.
He also founded Ranger Biotechnologies A in 2009, where he currently holds the title of Chief Executive Officer & Director.
In addition to his founding positions, Dr. Moller has worked as a Principal at CEM Innovation A.
Postes actifs de Hans Thorleif Moller
| Sociétés | Poste | Début |
|---|---|---|
Ranger Biotechnologies A/S
 Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Fondateur | 01/07/2009 |
Anciens postes connus de Hans Thorleif Moller
| Sociétés | Poste | Fin |
|---|---|---|
CEM Innovation A/S
 CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark. | Corporate Officer/Principal | 18/03/2011 |
Profylakse ApS
 Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
CEM Innovation A/S
CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark. | Non-Energy Minerals |
Profylakse ApS
Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
Ranger Biotechnologies A/S
Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |
